Silver Nanoparticles: A Versatile Tool Against Infectious and Non-Infectious Diseases.

Sara Gonz��lez-Fern��ndez, Noelia Blanco-Agud��n, David Rodr��guez, Iv��n Fern��ndez-Vega, Jes��s Merayo-Lloves, Luis M Quir��s
Author Information
  1. Sara Gonz��lez-Fern��ndez: Department of Functional Biology, University of Oviedo, 33006 Oviedo, Spain. ORCID
  2. Noelia Blanco-Agud��n: Department of Functional Biology, University of Oviedo, 33006 Oviedo, Spain. ORCID
  3. David Rodr��guez: Department of Biochemistry and Molecular Biology, University of Oviedo, 33006 Oviedo, Spain. ORCID
  4. Iv��n Fern��ndez-Vega: Instituto Universitario Fern��ndez-Vega, Fundaci��n de Investigaci��n Oftalmol��gica, University of Oviedo, 33012 Oviedo, Spain. ORCID
  5. Jes��s Merayo-Lloves: Instituto Universitario Fern��ndez-Vega, Fundaci��n de Investigaci��n Oftalmol��gica, University of Oviedo, 33012 Oviedo, Spain.
  6. Luis M Quir��s: Department of Functional Biology, University of Oviedo, 33006 Oviedo, Spain. ORCID

Abstract

Silver nanoparticles possess remarkable properties that render them highly beneficial for medical applications in both infectious and non-infectious diseases. Among their most renowned attributes is their antimicrobial activity. They have demonstrated efficacy against a wide range of bacteria, fungi, protozoa, and viruses. Additionally, the antitumor and anti-diabetic properties of silver nanoparticles, along with their ability to promote wound healing and their application as biosensors, underscore their therapeutic potential for various non-infectious conditions. As silver nanoparticles are employed for medical purposes, their potential toxicity must be considered. While silver nanoparticles present a promising alternative in the therapeutic domain, further research is needed to elucidate their precise mechanisms of action, optimize their efficacy, and mitigate any potential health risks associated with their use.

Keywords

References

  1. Front Cell Infect Microbiol. 2023 Apr 06;13:1137947 [PMID: 37091673]
  2. Sci Rep. 2022 Dec 21;12(1):22109 [PMID: 36543812]
  3. Biotechnol Appl Biochem. 2023 Apr;70(2):885-894 [PMID: 36126095]
  4. Biomedicines. 2022 Sep 21;10(10): [PMID: 36289615]
  5. Molecules. 2023 Jun 26;28(13): [PMID: 37446657]
  6. ACS Nano. 2021 Jan 26;15(1):125-148 [PMID: 33306354]
  7. Appl Microbiol Biotechnol. 2022 Oct;106(19-20):6365-6381 [PMID: 36089638]
  8. Adv Sci (Weinh). 2022 Oct;9(29):e2203291 [PMID: 36031384]
  9. Microorganisms. 2023 Sep 07;11(9): [PMID: 37764092]
  10. Microorganisms. 2022 Feb 14;10(2): [PMID: 35208891]
  11. J Med Entomol. 2024 Nov 14;61(6):1427-1434 [PMID: 39209797]
  12. J Appl Toxicol. 2023 Jan;43(1):4-21 [PMID: 35285037]
  13. Adv Mater. 2021 Jan;33(1):e2005448 [PMID: 33230875]
  14. G3 (Bethesda). 2023 Mar 9;13(3): [PMID: 36635051]
  15. Pestic Biochem Physiol. 2019 Jun;157:45-52 [PMID: 31153476]
  16. Heliyon. 2023 Jun 02;9(6):e16928 [PMID: 37346326]
  17. Front Microbiol. 2021 Dec 17;12:750556 [PMID: 34975782]
  18. Int J Mol Sci. 2024 Nov 03;25(21): [PMID: 39519360]
  19. Polymers (Basel). 2022 Aug 01;14(15): [PMID: 35956652]
  20. Int J Mol Sci. 2021 Oct 19;22(20): [PMID: 34681930]
  21. Sensors (Basel). 2021 Jul 28;21(15): [PMID: 34372350]
  22. Front Microbiol. 2021 Apr 16;12:652863 [PMID: 33936010]
  23. Sci Rep. 2023 Jul 12;13(1):11274 [PMID: 37438609]
  24. Inflammation. 2023 Aug;46(4):1512-1530 [PMID: 37212952]
  25. Biomolecules. 2022 Oct 26;12(11): [PMID: 36358913]
  26. Sci Rep. 2022 Oct 27;12(1):18046 [PMID: 36302952]
  27. Antimicrob Agents Chemother. 2022 Jun 21;66(6):e0203121 [PMID: 35604211]
  28. Braz J Microbiol. 2021 Dec;52(4):1701-1718 [PMID: 34558029]
  29. Microorganisms. 2023 Feb 01;11(2): [PMID: 36838334]
  30. Nanomaterials (Basel). 2025 Jan 27;15(3): [PMID: 39940178]
  31. Cancers (Basel). 2023 Jul 14;15(14): [PMID: 37509279]
  32. Front Microbiol. 2019 Dec 04;10:2709 [PMID: 31866956]
  33. Int J Mol Sci. 2021 Jul 04;22(13): [PMID: 34281254]
  34. J Nanobiotechnology. 2011 Aug 03;9:30 [PMID: 21812950]
  35. J Vet Pharmacol Ther. 2021 May;44(3):281-297 [PMID: 33277732]
  36. Bioinorg Chem Appl. 2022 Sep 23;2022:8546079 [PMID: 36193250]
  37. Environ Sci Ecotechnol. 2023 Oct 01;19:100325 [PMID: 38046179]
  38. Environ Pollut. 2021 Jan 1;268(Pt B):115913 [PMID: 33143973]
  39. Pathogens. 2022 Sep 20;11(10): [PMID: 36297126]
  40. Environ Pollut. 2025 Feb 15;367:125643 [PMID: 39761711]
  41. Environ Monit Assess. 2023 Nov 10;195(12):1442 [PMID: 37945767]
  42. Saudi J Biol Sci. 2022 Apr;29(4):2085-2094 [PMID: 35531241]
  43. Bioorg Chem. 2023 Jul;136:106551 [PMID: 37094480]
  44. Animals (Basel). 2021 Jun 24;11(7): [PMID: 34202806]
  45. Res Pharm Sci. 2014 Nov-Dec;9(6):385-406 [PMID: 26339255]
  46. J Appl Toxicol. 2018 May;38(5):638-648 [PMID: 29218775]
  47. Int J Nanomedicine. 2022 Apr 26;17:1851-1864 [PMID: 35502235]
  48. Biochem Biophys Res Commun. 2020 Nov 26;533(1):195-200 [PMID: 32958250]
  49. Polymers (Basel). 2023 Feb 28;15(5): [PMID: 36904479]
  50. Int J Mol Sci. 2020 Oct 16;21(20): [PMID: 33081366]
  51. Sci Rep. 2024 Feb 15;14(1):3809 [PMID: 38360831]
  52. Adv Biol (Weinh). 2022 Jul;6(7):e2200005 [PMID: 35398976]
  53. Int J Mol Sci. 2023 Mar 07;24(6): [PMID: 36982206]
  54. Int J Nanomedicine. 2021 Oct 22;16:7181-7194 [PMID: 34712048]
  55. Sci Rep. 2023 Jun 6;13(1):9202 [PMID: 37280318]
  56. Plants (Basel). 2021 May 20;10(5): [PMID: 34065251]
  57. Molecules. 2022 Aug 30;27(17): [PMID: 36080353]
  58. Int J Nanomedicine. 2018 May 03;13:2647-2663 [PMID: 29760548]
  59. Recent Pat Nanotechnol. 2024;18(3):361-373 [PMID: 37106512]
  60. J Funct Biomater. 2023 Apr 26;14(5): [PMID: 37233354]
  61. Biol Trace Elem Res. 2022 Apr;200(4):1699-1709 [PMID: 34114175]
  62. Eur Rev Med Pharmacol Sci. 2023 Jan;27(2):744-754 [PMID: 36734730]
  63. Nanotechnology. 2021 Jun 17;32(36): [PMID: 34020439]
  64. Sci Total Environ. 2020 Jul 10;725:138433 [PMID: 32302844]
  65. Front Chem. 2022 Oct 06;10:1023542 [PMID: 36277355]
  66. Sci Rep. 2020 Oct 22;10(1):18097 [PMID: 33093606]
  67. Nanomedicine (Lond). 2011 Jul;6(5):879-98 [PMID: 21793678]
  68. Chemosphere. 2022 Apr;293:133511 [PMID: 34995626]
  69. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Sep;13(5):e1707 [PMID: 33638618]
  70. Colloids Surf B Biointerfaces. 2023 Feb;222:113089 [PMID: 36527806]
  71. Molecules. 2011 Oct 24;16(10):8894-918 [PMID: 22024958]
  72. Appl Biochem Biotechnol. 2022 Mar;194(3):1136-1148 [PMID: 35091876]
  73. Drug Chem Toxicol. 2023 Nov;46(4):768-780 [PMID: 35801365]
  74. Int J Mol Sci. 2020 Aug 16;21(16): [PMID: 32824343]
  75. J Nanobiotechnology. 2021 Sep 27;19(1):291 [PMID: 34579731]
  76. Exp Biol Med (Maywood). 2023 Dec;248(23):2237-2248 [PMID: 38205769]
  77. Biomed Rep. 2024 Feb 21;20(4):65 [PMID: 38476608]
  78. Microorganisms. 2022 May 24;10(6): [PMID: 35744595]
  79. Molecules. 2023 Jun 10;28(12): [PMID: 37375242]
  80. Environ Sci Pollut Res Int. 2020 Mar;27(8):8058-8070 [PMID: 31897981]
  81. AMB Express. 2021 Apr 26;11(1):61 [PMID: 33900505]
  82. J Trace Elem Med Biol. 2021 Sep;67:126774 [PMID: 33984543]
  83. Cardiovasc Diabetol. 2024 Feb 10;23(1):62 [PMID: 38341550]
  84. Opt Express. 2023 Jun 19;31(13):21586-21613 [PMID: 37381254]
  85. Clin Orthop Relat Res. 2021 Jul 1;479(7):1471-1481 [PMID: 33835090]
  86. Environ Sci Pollut Res Int. 2024 Feb;31(6):8400-8428 [PMID: 38182947]
  87. Nanoscale. 2021 Dec 2;13(46):19306-19323 [PMID: 34783806]
  88. Molecules. 2020 Apr 26;25(9): [PMID: 32357560]
  89. Int J Mol Sci. 2022 Jan 13;23(2): [PMID: 35055024]
  90. J Hematol Oncol. 2022 Sep 12;15(1):132 [PMID: 36096856]
  91. Drug Deliv Transl Res. 2022 Aug;12(8):1881-1894 [PMID: 35359261]
  92. Sci Total Environ. 2022 Oct 10;842:156807 [PMID: 35750161]
  93. Biomolecules. 2019 Dec 30;10(1): [PMID: 31905962]
  94. Molecules. 2024 Apr 26;29(9): [PMID: 38731501]
  95. Int J Mol Sci. 2020 Mar 30;21(7): [PMID: 32235542]
  96. J Appl Microbiol. 2022 Jan;132(1):244-255 [PMID: 34134177]
  97. Cell. 2023 Sep 14;186(19):4059-4073.e27 [PMID: 37611581]
  98. Nanomaterials (Basel). 2024 Aug 31;14(17): [PMID: 39269087]
  99. Antibiotics (Basel). 2022 Aug 03;11(8): [PMID: 36009923]
  100. Saudi J Biol Sci. 2021 Apr;28(4):2229-2235 [PMID: 33935565]
  101. Chem Asian J. 2022 Mar 1;17(5):e202101149 [PMID: 35020270]
  102. Colloids Surf B Biointerfaces. 2022 Feb;210:112254 [PMID: 34896692]
  103. J Ovarian Res. 2022 Nov 21;15(1):121 [PMID: 36411490]
  104. Anal Chim Acta. 2008 Mar 24;611(2):205-11 [PMID: 18328322]
  105. ACS Sens. 2021 Jun 25;6(6):2320-2329 [PMID: 34033456]
  106. IUBMB Life. 2000 Oct-Nov;50(4-5):279-89 [PMID: 11327322]
  107. Nanoscale. 2020 Jan 28;12(4):2384-2392 [PMID: 31930233]
  108. Adv Colloid Interface Sci. 2022 Aug;306:102726 [PMID: 35785596]
  109. Toxicol Lett. 2008 Jul 10;179(3):130-9 [PMID: 18547751]
  110. Nature. 2024 Feb;626(7997):177-185 [PMID: 38123686]
  111. Clin Pharmacol Ther. 2021 Apr;109(4):905-917 [PMID: 33539569]
  112. Sci Total Environ. 2014 Jan 15;468-469:968-76 [PMID: 24091120]
  113. Nat Rev Microbiol. 2023 Dec;21(12):789-804 [PMID: 37542123]
  114. Cancers (Basel). 2020 Jul 28;12(8): [PMID: 32731591]
  115. BMC Microbiol. 2020 Jun 19;20(1):172 [PMID: 32560673]
  116. Curr Microbiol. 2024 Apr 20;81(6):149 [PMID: 38642138]
  117. Sci Rep. 2023 Jan 16;13(1):790 [PMID: 36646714]
  118. Front Microbiol. 2024 Apr 08;15:1376669 [PMID: 38650875]
  119. Front Microbiol. 2021 Oct 11;12:742027 [PMID: 34707592]
  120. ADMET DMPK. 2022 Feb 02;10(2):115-129 [PMID: 35350114]
  121. Biomed Res Int. 2024 Feb 19;2024:7145339 [PMID: 38410788]
  122. Appl Biochem Biotechnol. 2024 Jun;196(6):3636-3669 [PMID: 37668757]
  123. Microbiol Spectr. 2015 Jun;3(3): [PMID: 26185074]
  124. Int J Mol Sci. 2022 Aug 28;23(17): [PMID: 36077148]
  125. Int J Mol Sci. 2022 May 27;23(11): [PMID: 35682703]
  126. Microsc Res Tech. 2024 Oct;87(10):2292-2300 [PMID: 38747100]
  127. Nanomaterials (Basel). 2022 Mar 22;12(7): [PMID: 35407153]
  128. Int J Mol Sci. 2021 Aug 11;22(16): [PMID: 34445327]
  129. Nanomaterials (Basel). 2020 Aug 09;10(8): [PMID: 32784939]
  130. J Pers Med. 2022 Nov 09;12(11): [PMID: 36579581]
  131. Mikrochim Acta. 2023 Feb 15;190(3):91 [PMID: 36790481]
  132. Arch Virol. 2023 Jan 5;168(1):32 [PMID: 36604362]
  133. Front Microbiol. 2017 Oct 10;8:1878 [PMID: 29067003]
  134. J Genet Eng Biotechnol. 2021 Sep 23;19(1):140 [PMID: 34557983]
  135. Nanomaterials (Basel). 2022 Jul 05;12(13): [PMID: 35808152]
  136. Sci Rep. 2018 Feb 5;8(1):2445 [PMID: 29402973]
  137. ChemMedChem. 2020 Sep 3;15(17):1619-1623 [PMID: 32657536]
  138. Mini Rev Med Chem. 2021;21(14):1798-1812 [PMID: 33535949]
  139. J Mater Chem B. 2023 Mar 1;11(9):1904-1915 [PMID: 36734837]
  140. Lett Appl Microbiol. 2023 Jan 23;76(1): [PMID: 36688766]
  141. Environ Res. 2024 May 1;248:118313 [PMID: 38280527]
  142. Front Microbiol. 2024 Jul 31;15:1440065 [PMID: 39149204]
  143. J Clin Invest. 2023 Oct 16;133(20): [PMID: 37651203]
  144. Int J Mol Sci. 2023 Mar 17;24(6): [PMID: 36982857]
  145. Sci Rep. 2021 Jun 2;11(1):11610 [PMID: 34078983]
  146. Mater Sci Eng C Mater Biol Appl. 2021 Aug;127:112249 [PMID: 34225888]
  147. Microorganisms. 2023 Feb 28;11(3): [PMID: 36985203]
  148. Front Microbiol. 2023 Jan 31;13:1064095 [PMID: 36798870]
  149. Biomed Pharmacother. 2021 May;137:111294 [PMID: 33571836]
  150. Microbiology (Reading). 2023 May;169(5): [PMID: 37224055]
  151. Sci Rep. 2022 Nov 5;12(1):18746 [PMID: 36335167]
  152. Molecules. 2022 Jul 25;27(15): [PMID: 35897928]
  153. Front Oncol. 2025 Jan 08;14:1465987 [PMID: 39845315]
  154. Viruses. 2018 Sep 26;10(10): [PMID: 30261662]
  155. Environ Sci Pollut Res Int. 2018 Sep;25(27):27021-27030 [PMID: 30014367]
  156. Biol Trace Elem Res. 2024 May;202(5):1878-1900 [PMID: 37639166]
  157. Toxicol In Vitro. 2010 Apr;24(3):872-8 [PMID: 19969064]
  158. J Appl Toxicol. 2022 Dec;42(12):1890-1900 [PMID: 35212001]
  159. Nanomaterials (Basel). 2022 Jul 30;12(15): [PMID: 35957067]

Grants

  1. FPU20/06016/Ministerio de Universidades. Spain

Word Cloud

Created with Highcharts 10.0.0nanoparticlessilverpotentialSilverpropertiesmedicalnon-infectiousantimicrobialefficacywoundhealingbiosensorstherapeuticpossessremarkablerenderhighlybeneficialapplicationsinfectiousdiseasesAmongrenownedattributesactivitydemonstratedwiderangebacteriafungiprotozoavirusesAdditionallyantitumoranti-diabeticalongabilitypromoteapplicationunderscorevariousconditionsemployedpurposestoxicitymustconsideredpresentpromisingalternativedomainresearchneededelucidateprecisemechanismsactionoptimizemitigatehealthrisksassociateduseNanoparticles:VersatileToolInfectiousNon-InfectiousDiseasesbiofilmcancerdiabetesions

Similar Articles

Cited By